Pending FDA approval: Cardinal Health to ready formulation for market

Article

Irvine, CA-ISTA Pharmaceuticals and Cardinal Health will manufacture commercial quantities of Vitrase, a proprietary formulation of highly purified hyaluronidase, pending its FDA approval.

Related Videos
This series features 1 KOL.
This series features 1 KOL.
This series features 1 KOL.
Alice Epitropoulos, MD, and Laura M. Periman, MD
Alice Epitropoulos, MD, and Laura M. Periman, MD
Video 2 - 1 KOL is featured in, "Advances in Technology for SMILE procedure"
© 2024 MJH Life Sciences

All rights reserved.